HCSG · Healthcare Services Group Inc

Track HCSG — free

$20.50 +0.05 (+0.24%)

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$1.44B

68.63M

Volume · Sep 30 677.91K Avg daily vol (3M) 704.27K

Up next

Next earnings call

Oct 21, 2026 Scheduled · in 3 wks

Latest filing: 10-Q

filed Jul 24, 2026

Q2 2026 earnings call transcript

call held Jul 22, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$1.86B

Trailing 12 months

Net income (TTM)

$122.95M

Trailing 12 months

Revenue growth YoY

+2.7%

Year over year

Operating margin

—

Trailing 12 months

P / E (TTM)

12.2

Trailing earnings · reciprocal yield 8.2%

FCF yield

10.3%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$164.72M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

-4.5%

Year over year · fewer shares

Price change (1Y)

+26.7%

Trailing year

Short interest

4.4%

Latest settlement · 5.8 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Sell Momentum Neutral Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate

Market backdrop VIX 16.3 · calm Equity put/call 0.53

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −3%

below

Price vs 50-day avg −7%

below

RSI (14) 30

neutral

MACD trend Negative

52-week position 52%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Neutral

1-month return −6%

trailing

6-month return +6%

trailing

YTD return +7%

this year

Relative strength −6%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $22 › 200d $21 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +47 funds added

Insider flow Distributing

Net -$362.5K over 90 days · 100% sells

Short interest Rising

4.43% of float · ▲ +6.4% MoM · 5.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

274 holders — near 3-yr high, broad support

Squeeze score 58

elevated · 0–100

Fundamentals

Excellent

Revenue growth +7%

Y/Y

EPS growth +53%

Y/Y

Free cash flow $139.2M

Valuation P/E 12.3

below peers

Buyback $30.1M

remaining

Quant / Vol

risk profile

Moderate

Volatility 42%

annualized · 1-yr

Max drawdown −20%

past year

ATR 2.6%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 5 of last 5

Latest guidance · from the Earnings Call filed Jul 22, 2026

the 86% range

Cost of services 86%

the 9.5 to 10.5 percent range

SG&A 9.5% – 10.5%

2026

Effective tax rate 25%

third quarter

Revenue $475M – $485M

prior qtr $470.81M midpoint +2.0% QoQ

longer-term goal

SG&A 8.5% – 9.5%

Guided vs delivered · last 5 settled

Revenue Q3

guided $425M – $435M

guided $425M – $435M $428.15M In line

Revenue Q4

guided $430M – $440M

guided $430M – $440M $437.81M In line

Revenue Q2 2024

guided $420M – $430M

guided $420M – $430M $426.29M In line

Q4 revenue Q4

guided $420M – $430M

guided $420M – $430M $423.84M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

2 · 5 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−3% Neutral

Price vs 50-day avg

−7% Bearish

RSI (14)

30 Neutral

MACD trend

Negative Bearish

52-week position

52% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $22 › 200d $21 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +47 funds added

Insider flow Distributing

Net -$362.5K over 90 days · 100% sells

Short interest Rising

4.43% of float · ▲ +6.4% MoM · 5.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

274 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $15 Now $20 · 52% Range high $25

vs 200-day avg -3% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Costs of services provided as a percentage of revenues	84.1%	three months ended June 30, 2026 filing	—
Dietary labor and labor-related costs as a percentage of segment revenue	58.2%	three months ended June 30, 2026 filing	—
EVS labor and labor-related costs as a percentage of segment revenue	76.6%	three months ended June 30, 2026 filing	—
Segment expenses for Dietary as a percentage of Dietary revenues	92.5%	three months ended June 30, 2026 filing	—
Segment expenses for EVS as a percentage of EVS revenues	86.7%	three months ended June 30, 2026 filing	—
Segment margin	13.3%	Three Months Ended June 30, 2026 filing	—
Segment profit	$47.63M	Three Months Ended June 30, 2026 filing	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
HCSG Healthcare Services Group Inc this stock	$1.44B	+7.0%	+7.1%	12.3	4.4%
HCA HCA Healthcare, Inc.	$96.64B	-8.6%	+7.1%	15.0	2.9%
FSNUY Fresenius SE & Co. KGaA	$29.92B	-11.6%	—	—	0.0%
THC Tenet Healthcare Corp	$20.91B	+28.6%	+0.9%	10.0	2.5%
EHC Encompass Health Corp	$12.18B	+14.5%	+10.5%	20.1	3.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

274

% held: 104.2%
Net QoQ: -758.6K sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

334

View

Short & Settlement

Short Interest Rising

Shares short

3.0M

Days to cover: 5.8d
Change: +181.9K sh

View

Short Volume

Short vol %

40%

As of: Sep 30, 2026

Short Total

View

Fails to Deliver

FTD shares

144

Value: $3.1K
As of: Sep 8, 2026

View

Off-Exchange

Off-exchange %

36.0%

Week of: Aug 24, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$362.5K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Congressional Trades Buy

Member

Greg Gianforte

Amount: $50.0K–$100.0K
Traded: Apr 30, 2020

View

Financials

Revenue (FY)

$1.8B

Net income (FY): $59.1M
EPS diluted: $0.81

View

Buybacks

Authorized

shares 10.0M

Remaining: $30.1M

View

Filings

SEC Filings

Latest

10-Q

Filed: Jul 24, 2026
This year: 9

View

Proposed Sales

Value

$362.5K

Shares: 15.6K
Filed: Aug 4, 2026

View

Earnings & Events

Earnings Calls Upcoming

Next call

Oct 21, 2026

Last call: Jul 22, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
HCSG	-3.8%	-6.3%	+5.8%	-7.0%	+7.0%
SPY	-0.7%	+0.1%	+12.2%	-0.6%	+11.8%
vs SPY	-3.1%	-6.4%	-6.4%	-6.4%	-4.9%

Capital returns

Buyback program · as of Jun 30, 2026

Authorized

shares 10.00M

Spent (derived)

—

Remaining

$30.10M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 731012 CUSIP 421906108 13F (30d) 8 filings 8 filers Visit website Investor relations

HCSG · Healthcare Services Group Inc

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns